CA2678776A1 - Orthostasis detection system and method - Google Patents
Orthostasis detection system and method Download PDFInfo
- Publication number
- CA2678776A1 CA2678776A1 CA002678776A CA2678776A CA2678776A1 CA 2678776 A1 CA2678776 A1 CA 2678776A1 CA 002678776 A CA002678776 A CA 002678776A CA 2678776 A CA2678776 A CA 2678776A CA 2678776 A1 CA2678776 A1 CA 2678776A1
- Authority
- CA
- Canada
- Prior art keywords
- maneuver
- positional
- orthostasis
- patient
- occurrence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000002173 dizziness Diseases 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title abstract description 22
- 238000001514 detection method Methods 0.000 title description 14
- 230000000004 hemodynamic effect Effects 0.000 claims abstract description 34
- 230000004044 response Effects 0.000 claims abstract description 10
- 238000012544 monitoring process Methods 0.000 claims abstract description 7
- 230000001144 postural effect Effects 0.000 claims description 2
- 229910003798 SPO2 Inorganic materials 0.000 description 13
- 101100478210 Schizosaccharomyces pombe (strain 972 / ATCC 24843) spo2 gene Proteins 0.000 description 13
- 230000008859 change Effects 0.000 description 12
- 230000036772 blood pressure Effects 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 229940079593 drug Drugs 0.000 description 9
- 230000000241 respiratory effect Effects 0.000 description 8
- 230000029058 respiratory gaseous exchange Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036387 respiratory rate Effects 0.000 description 6
- 239000002131 composite material Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035488 systolic blood pressure Effects 0.000 description 4
- 238000009423 ventilation Methods 0.000 description 4
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002746 orthostatic effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 208000013433 lightheadedness Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001991 pathophysiological effect Effects 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010003840 Autonomic nervous system imbalance Diseases 0.000 description 1
- 208000009079 Bronchial Spasm Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 208000032131 Diabetic Neuropathies Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- -1 MOAI Substances 0.000 description 1
- 208000027089 Parkinsonian disease Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 208000008784 apnea Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000003693 atypical antipsychotic agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 229940052760 dopamine agonists Drugs 0.000 description 1
- 239000003136 dopamine receptor stimulating agent Substances 0.000 description 1
- 229940093334 flomax Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000005399 mechanical ventilation Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000008510 paroxysmal tachycardia Diseases 0.000 description 1
- 244000144985 peep Species 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- ZZIZZTHXZRDOFM-XFULWGLBSA-N tamsulosin hydrochloride Chemical compound [H+].[Cl-].CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 ZZIZZTHXZRDOFM-XFULWGLBSA-N 0.000 description 1
- VCKUSRYTPJJLNI-UHFFFAOYSA-N terazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1CCCO1 VCKUSRYTPJJLNI-UHFFFAOYSA-N 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000003639 vasoconstrictive effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/024—Detecting, measuring or recording pulse rate or heart rate
- A61B5/02416—Detecting, measuring or recording pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4884—Other medical applications inducing physiological or psychological stress, e.g. applications for stress testing
Abstract
The disclosed embodiments relate to a system 100 and method 200 for monitoring patient data. An exemplary method comprises obtaining hemodynamic variation data 204 that corresponds to a variation in intravascular hemodynamics of a patient, searching the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient 206, and generating an output if the indication orthostasis is discovered 208.
Description
ORTHOSTASIS DETECTION SYSTEM AND METHOD
1. Technical Field [0001] This invention relates systems and methods for detecting and monitoring adverse disorders in clinical medicine.
1. Technical Field [0001] This invention relates systems and methods for detecting and monitoring adverse disorders in clinical medicine.
2. Background Art [0002] Acute reductions in venous return and, in particular, orthostasis resulting from positional induction of acute reduction of venous return are potential problems in hospitals, nursing homes and in the home environment. Orthostasis, which is a sudden fall in blood pressure when a person assumes a standing position, is a cause of falls and injury and is commonly induced by medication. The conventional standard technique for detecting orthostasis using paired supine and standing blood pressure measurements is cumbersome and, therefore, often not applied by medical personnel, placing the patient at risk for repeated falls. Also, the conventional technique provides only a limited picture of the hemodynamic response to position change. The blood pressure may drop suddenly and quickly return so that the standing blood pressure may miss the drop. The standing or the Valsalva maneuvers are both associated with both a fall in venous return (which reduces stroke volume) and compensatory vasoconstriction.
Both of these physiologic events cause a fall in the waveform amplitude of a plethysmographic pulse signal of a patient in response to the maneuver. In some patients with autonomic dysfunction, compensatory vasoconstriction is defective; however, these patients may have severe drops in venous return so that a fall in the pleth waveform amplitude still occurs with standing.
An improved system and method of detecting orthostasis is desirable.
BRIEF DESCRIPTION OF DRAWINGS
Both of these physiologic events cause a fall in the waveform amplitude of a plethysmographic pulse signal of a patient in response to the maneuver. In some patients with autonomic dysfunction, compensatory vasoconstriction is defective; however, these patients may have severe drops in venous return so that a fall in the pleth waveform amplitude still occurs with standing.
An improved system and method of detecting orthostasis is desirable.
BRIEF DESCRIPTION OF DRAWINGS
[0003] FIG. 1 is a block diagram of a system that is adapted to analyze data corresponding to variations in a plethysmographic pulse signal in accordance with an exemplary embodiment of the present invention; and [0004] FIG. 2 is a process flow diagram illustrating a method of processing patient data in accordance with an exemplary embodiment of the present invention.
MODES FOR CARRYING OUT THE INVENTION
[00051 An exemplary embodiment of the present invention comprises an orthostasis detection system and method and a venous return assessment system and method.
Furthermore, exemplary embodiments of the present invention may comprise a system and method to identify a timed pattern of orthostasis to, for example, identify patients with more sustained patterns of blood pressure fall or with incomplete recovery after the fall. Accordingly, an exemplary orthostasis detection system comprises a hemodynamic signal detector, such as a pulse oximeter, an input device for automatically or manually inputting an occurrence of a maneuver, such as standing or a Valsalva maneuver), and a processor for generating a time series of a hemodynamic signal (such as a plethysmographic pulse signal) and for outputting an indication based on both the maneuver and the time series. In one exemplary embodiment, the processor is programmed to determine at least one variation of the pulse signal (such as the systolic variation of the plethysmographic pulse), to output a time series of the variation and to detect a threshold and/or pattern of variation and to output an indication based on the detection. The variation of the plethysmographic pulse signal is one example of hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient. In another exemplary embodiment, the processor outputs a signal corresponding to at least one pleth waveform component prior to standing (such as the amplitude of the pleth signal, for example, the average minimum of the pleth signal, the average maximum amplitude of the pleth signal, or a value indicative of a respiratory-related plethysmographic waveform variation). The processor then outputs the pattern or value indicative of at least one pleth waveform component after standing and then compares the value or pattern prior to standing with the value or pattern after standing. Examples of input devices that can be used to detect when the patient stands include, for example, a patient-mounted position sensor or a manual input device such as a mouse or keyboard. In an exemplary embodiment of the present invention, a position sensor is worn by a patient to communicate postural position information about the patient to the processor. The processor can determine and/or calculate the difference between the pre-standing and post standing values. Exemplary embodiments of the present invention may provide an orthostasis detection system that is simple, inexpensive, non-invasive, automated, and can be employed in a long-term ambulatory state.
[0006] One exemplary embodiment of detecting orthostasis according to the present invention comprises measuring at least one pleth waveform component, inputting the occurrence of a maneuver on a patient into a processor, measuring at least one pleth waveform component after the maneuver, comparing the pleth waveform component measured before the maneuver to the pleth waveform component after the maneuver. Another exemplary embodiment includes the acts of deriving a time series of a pleth waveform component, providing an indication of the time of at least one maneuver along the time series and outputting the time series.
Another exemplary embodiment may include the act of comparing a pleth waveform pattern before a maneuver to the pleth waveform pattern after the maneuver.
[00071 FIG. 1 is a block diagram of a system that is adapted to analyze data corresponding to variations in a plethysmographic pulse signal in accordance with an exemplary embodiment of the present invention. The system is generally referred to by the reference number 100. The system 100 comprises a pulse oximeter 102, which is connected to a processor 104. The processor 104 may be programmed to perform calculations and analysis on data corresponding to variations in a plethysmographic pulse signal. In the exemplary embodiment illustrated in FIG.
1, the pulse oximeter 102 is adapted to receive plethysmographic pulse data from a plethysmographic sensor 106, which may be connected to a patient. In an alternative embodiment, the processor 104 may be adapted to analyze previously obtained data stored in a memory 108, which is coupled to the processor 104. The exemplary system 100 may include an input device 110 to signal the performance of a maneuver by or on a patient. In this way, data being evaluated by the system 100 may be analyzed in the context of when it occurred relative to the performance of the maneuver. While an exemplary embodiment of the invention comprises the pulse oximeter 102.
other devices that detect and/or monitor a hemodynamic pulse related parameter such as, for example, a pressure transduced arterial catheter, a continuous blood pressure monitor, or a digital volumetric plethysmograph, to name a few, may be employed to detect the hemodynamic and systolic pressure variations discussed below. The system 100 may additionally include an output device 112, such as a printer, display device, alarm or the like. The output device 112 may be adapted to signal or provide an indication of a condition detected by the processor 104.
[0008] Those of ordinary skill in the art appreciate that the detection and quantification of at least one pleth waveform component (such as magnitude of the respiratory related variation of the pleth) is possible. One method of processing the pleth signal is described in U.S. Patent No.
7,081,095 (the contents of which are incorporated by reference as if completely disclosed herein).
An example of a pleth waveform component is the pleth variation associated with ventilation as calculated from the plethysmographic pulse of the pulse oximeter 102, which is a sensitive indicator of intravascular blood volume in patients undergoing mechanical ventilation. The plethysmographic waveform (or pulse) variation can, for example, be outputted as a percentage of the peak pleth amplitude (see, for example, Pulse Oximetry Plethysmographic Waveform During Changes in Blood Volume, British Journal of Anesthesia, 82 (2): 178-81 (1999), the contents of which are hereby incorporated by reference as if completely disclosed herein).
100091 However, while a decrease in effective venous return (as induced by a decrease in blood volume) commonly increases the respiratory-related pleth waveform (or systolic pressure) variation, a rise in respiratory effort can also increase this variation so that the linkage of this variation to the intravascular volume becomes much more complex in spontaneously breathing patients. Simplistic approaches, which attempt to determine the trend of the this plethysmographic waveform variation to determine blood volume, can provide a false trend which may suggest a falling blood volume due to a plethysmographic waveform variation cased by a rising respiratory effort due to bronchospasm, pulmonary embolism, or even an excess in blood volume inducing pulmonary edema.
[0010] The inventors of the present invention has recognized that, because the pleth waveform variation increases with both a fall in effective venous return or an increase in respiratory effort (which can be associated with excess venous return and heart failure and increases in lung water), the pattern of the pleth waveform variation (or other pleth waveform components) are best analyzed in timed relation to a maneuver (such as a standing maneuver), which is known to reduce venous return, especially in disease states and in the presence of certain medications or in states of low blood volume so that the relationship of the change in pleth waveform variation to the maneuver can be determined to thereby better establish the presence of reduced venous return and to identify when the magnitude of venous return and/or the vasoconstrictive arterial response to a decline in venous return, is abnormal.
[0011] In an exemplary embodiment of the present invention, the processor 104 is programmed to detect a falling SPO2 combined with a rising magnitude of the pleth respiratory variation or a change or a pattern of change in a plethysmographic pulse component in relation to a maneuver that potentially reduces venous return, such as standing. In an exemplary embodiment of the present invention, the processor 104 can be programmed, as by using an objectification method, to convert the plethysmographic time series into program objects such as dipoles (see, e.g. U.S. Patent Application Serial No. 10/150,842 filed on August 21, 2003 (now U.S. Patent Publication No. 20030158466), the contents of which are incorporated by reference as if completely disclosed herein) and objects comprised of events such as rises and falls and reciprocations (fundamental level).
[0012] Reciprocation objects can be defined by the user or by adaptive processing, as a threshold or pattern of reduction of amplitude, peak value, nadir value, slope, area under the curve (AUC) or the like. The components of the rises and falls such as the peaks, the nadirs, the slopes, or the AUC, to name a few, can be applied to render the composite level of the plethysmographic time series. The pattern of the reciprocations of one or more of these values (the composite level) can use used to detect respiration rate wherein the respiration rate is defined as the average number of reciprocations at the composite level per minute. More complex variations in the pattern of the plethysmographic pulse will also be detectable at the composite level such as apneas or sustained variations in blood flow to the finger (as, for example, may be induced by a mechanical ventilator setting change or a change in body position from the supine to the upright position). The SPO2 can be similarly processed in parallel with the pulse and the pattern of the pulse at the any level of the pulse compared with the pattern of the SPO2 at any level.
[0013] In an exemplary embodiment of the present invention, the number of reciprocations per minute and/or the magnitude of the amplitude of the reciprocations, amplitude, as determined by calculating the number of reciprocations per minute, is compared using the processor 104 with the time series of the SPO2 at, for example, the raw, dipole or fundamental level. The relationship between these two time series determined by the processor 104 may be used to detect and quantify the relationship between the ventilation time series (derived of the plethysmographic pulse) and the oxygen saturation time series.
[00141 In an exemplary embodiment of the present invention, the processor 104 is programmed to detect a change (such as a fall) in a plethysmographic pulse component (as for example the components noted above) in response to a maneuver, which affects venous return to the heart. Examples of such maneuvers include changes in a mechanical ventilator (such as an increase in positive pressure delivery to the patient, an increase in positive and expiratory pressure delivery to the patient, a change or changes in tidal volume, PEEP, respiration rate, or I:E ratio).
Other maneuvers can include having the patient stand up from a supine position to detect a positional variation in the plethysmographic pulse parameter. The processor 104 can be programmed to automatically detect the maneuver or to receive an input from the input device 110 indicative of the occurrence or pattern of the maneuver. In an exemplary embodiment of the present invention, the input device 110 can be accessed through a menu which can allow the user to specify the maneuver (such as standing or exercising).
100151 In an exemplary embodiment of the present invention, the processor 104 is adapted to detect orthostasis. An input is provided via the input device 110 when the patient undergoes a maneuver such as a change in body position (for example, standing up). The beginning of the maneuver may be taken into account when analyzing the corresponding SPO2, respiration and ventilation data. A variation in a least one component of the plethysmographic pulse may be quantified and a relationship between the variation and the maneuver may be identified. By way of example, a fall in the average pleth amplitude (such as the systolic variation ) of about 20% or more in response to standing can result in an output that indicates to an.attendant that there is a need to check the blood pressure in the supine and standing position.
Alternatively, the processor 104 can be programmed to detect an increase in the reciprocation amplitude at the composite level of about 20-40% or more can output an indication of the presence and/or magnitude and/or pattern of orthostatic variation in the pleth amplitude pattern. In one exemplary embodiment of the present invention, the pulse oximeter 102 is adapted to be used for spot checks of the SPO2. The system may also be adapted to display a menu on, for example, either the input device 110 or the output device 112 depending on system design considerations. A user may specify that one or more orthostatic variation maneuver(s) is (are) to be initiated via the menu.
The user may then be instructed to press a button or touch the screen at the time the patient stands up. The processor 104 tracks the pattern of the pleth and outputs and detects threshold pattern changes or lack thereof as noted above. An indication (such as a textual indication or alarm) of the presence or absence of threshold orthostatic variation value and/or pattern may be provided. In addition, the slope or other components of the pattern of the variation subsequent to the maneuver can be determined and quantified. A time series indicative of the variation with the points of the standing or other position change marked along the time series may be outputted for over reading by the physician. Furthermore, a time series of one or more of the maneuvers may also be created. A time series of pleth variation data may be compared to the time series of one or more maneuvers.
[0016] In an alternative embodiment of the invention, the input device 110 comprises a position sensor adapted to be mounted in connection and/or in communication with one or more components of the system 100. The position sensor, which may be mounted to the chest of a patient during sleep studies, can alternatively be configured for mounting on the thigh of the patient so that detection of the change form recumbent to standing or sitting to standing is automatically performed by the position sensor. The plethysmographic monitor system 100 can have memory such as the memory 108 in wired and/or wireless communication therewith to allow ambulatory detection and quantification of the time series pattern of at least one plethysmographic pulse variation (such as a time series of the systolic pleth variation) in relation to variations in body position over a time interval such as 8-24 hours or more. Moreover, hemodynamic variation data may be obtained by ambulating a patient who is wearing a mobile hemodynamic variation detector. One example of ambulating the patient includes standing the patient while the patient is wearing a mobile hemodynamic variation detector. An exemplary embodiment of the present invention provides an ambulatory orthostasis detection system useful for titration of medications known to cause orthostasis. For example, the orthostasis monitor may be wrist mounted with the probe extending to the index finger. Such systems can be useful for the titration of medications used for the treatment of dementia in nursing homes or in the home environment. The system can also be used to titrate medication used for the treatment of heart failure or hypertension and for the ambulatory investigation of the cause of syncope or lightheadedness.
100171 In an exemplary embodiment of the present invention, the processor 104 is programmed to compare a time series of body position to a parallel time series of at least one component of the pleth variation. The time series of at least one component of the pleth variation is analyzed to detect patterns, which occur in relation to changes in body position. In addition, the pattern of the heart rate can be identified in relation to body position so that heart rate acceleration can be detected and quantified for example.
[0018] In another exemplary embodiment of the present invention, the plethysmographic monitor system 100 serves as a pulse rate and pattern detection system. The processor 104 is programmed to determine the time intervals of the pleth including the time between pulses, and the time of systole, the time of diastole, the time of the rise, the time of the fall, and the pattern of pulses. Different patterns can be detected such as the pattern of atrial fibrillation (for example, identified by detecting an irregularly irregular interval between pulses and/or an irregularly irregular pulse amplitude), or a paroxysmal tachycardia (for example, detected by noting a precipitous increase in pulse rate which resolves precipitously). This pulse rhythm and pulse amplitude diagnostic function is complementary to the orthostasis detection function for the evaluation of lightheadedness and syncope.
[0019] In yet another exemplary embodiment of the present invention, a time series of the respiratory rate (as for example determined from the pleth), a time series of the pleth variation, and a time series of the SPO2 are compared to identify the pattern relationships between these parameters such as a rise in pleth variation and a fall in SPO2, a rise in pleth variation and rise in respiratory rate, and/or a rise in respiratory rate and a fall in SPO2 and /or in relation to a maneuver such as standing. The processor 104 may be programmed to detect pathophysiologic divergence of the respiratory rate and/or the pleth variation and/or the SPO2.
[0020] In an exemplary embodiment of the present invention, an associated processor may be programmed to detect an oxygen saturation parameter (such as the ratio of ratios and/or the SPO2) and a respiration parameter (such as the respiration rate) and a magnitude of pleth variation. For example, the magnitude of pleth variation may be determined by the pleth amplitude and/or pleth slope variation. The pattern of the time series of the respiratory rate may then be compared with the pattern of the SPO2 to detect and abnormal relationship, such as pathophysiologic divergence with an increasing difference between the respiratory rate and the SPO2, for example. The processor may be programmed to output an indication based on the detection of the pattern or absolute value of the relationship and/or to output an index value indicative the relationship. The detection of a rise in respiration rate associated with a fall in plethysmographic pulse variation can be detected, quantified, and the pattern of the relationship analyzed and tracked by the processor.
The processor can be programmed to provide an updated indication of the relationship and the pattern of the relationship to the user. The method of processing can, for example, be of the type discussed in U.S. Patent No. 7,081,095 (the contents of which is incorporated by reference as if completely disclosed herein). In an exemplary embodiment of the present invention, a plurality of parameters are combined to determine the global respiratory variation, including the amplitude of the events (at the fundamental level), the variation of the peak values (fundamental level), and the variation of the nadirs (also fundamental level).
[0021] The system 100 may comprise an optional ventilator 114 operatively coupled to the processor 104. The ventilator 114 may comprise an airflow generator 116 that is adapted to an airflow to a patient. The processor 104 may be programmed so that the time series of the systolic pleth variation (for example) is displayed on the output device 112 adjacent a time series of at least one ventilation parameter. The processor 104 can be programmed for example to detect a pattern or threshold increase in systolic pressure variation in relation to a ventilator change and to output an indication of the pattern or threshold increase to the operator.
[0022] FIG. 2 is a process flow diagram illustrating a method of processing patient data in accordance with an exemplary embodiment of the present invention. The diagram is generally referred to by the reference number 200. At block 202, the process begins.
[0023] At block 204, hemodynamic variation data is obtained. The hemodynamic variation data, which corresponds to a variation in intravascular hemodynamics of a patient, may be obtained, for example, from a memory device or directly from monitoring a patient in real time.
At block 206, the hemodynamic variation data is searched for an indication of orthostasis in response to a maneuver performed on or by the patient. An output, such as an alarm, printout and/or display, is generated if the indication of orthostasis is detected, as indicated at block 208.
At block 210, the process ends.
[0024] One exemplary embodiment of the present invention comprises a method for determining the proper dose of a medication comprising administering the medication, monitoring the patient for orthostasis using the aforementioned methods, adjusting the dose of the medication based on the monitoring. The medications can include, for example, tricyclic antidepressants, MOAI, atypical antipsychotic agents, dopamine agonists, Flomax, Hytrin, diuretics, calcium channel blockers, and ACE inhibitors to name a few. Another exemplary embodiment comprises monitoring the patients with diseases or disorders for orthostasis using the aforementioned methods. The diseases or disorders can include, for example, dementia, Parkinsonian syndromes, diabetic neuropathy, and/or POTS to name a few.
[0025] In one exemplary embodiment of the present invention, an automated BP
device is modified to perform automated orthostasis evaluation on demand. The processor of the device is programmed to first measure the blood pressure, automatically or manually receive an input of a maneuver, such as a standing maneuver, then automatically acquire consecutive blood pressure readings in rapid sequence to determine and record a time series of blood pressure readings after the maneuver and to output an indication based on the time series. The automatic blood pressure device can be programmed to display a menu offering the operator an automated orthostasis evaluation. The processor can be programmed to constrict the cuff on the second measurement to a point to a lower pressure point than the systolic pressure (such as the point wherein the diastolic pressure had been identified on the first measurement) and then to record and analyze the pulse tracing detected under the partially constricted cuff (as by the aforementioned methods) for pulse variations during and after a maneuver. In one exemplary embodiment, the automated BP cuffs provide a selection in its display for orthostasis evaluation so the orthostasis can become a standard vital sign for some patient populations.
[0026] While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
MODES FOR CARRYING OUT THE INVENTION
[00051 An exemplary embodiment of the present invention comprises an orthostasis detection system and method and a venous return assessment system and method.
Furthermore, exemplary embodiments of the present invention may comprise a system and method to identify a timed pattern of orthostasis to, for example, identify patients with more sustained patterns of blood pressure fall or with incomplete recovery after the fall. Accordingly, an exemplary orthostasis detection system comprises a hemodynamic signal detector, such as a pulse oximeter, an input device for automatically or manually inputting an occurrence of a maneuver, such as standing or a Valsalva maneuver), and a processor for generating a time series of a hemodynamic signal (such as a plethysmographic pulse signal) and for outputting an indication based on both the maneuver and the time series. In one exemplary embodiment, the processor is programmed to determine at least one variation of the pulse signal (such as the systolic variation of the plethysmographic pulse), to output a time series of the variation and to detect a threshold and/or pattern of variation and to output an indication based on the detection. The variation of the plethysmographic pulse signal is one example of hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient. In another exemplary embodiment, the processor outputs a signal corresponding to at least one pleth waveform component prior to standing (such as the amplitude of the pleth signal, for example, the average minimum of the pleth signal, the average maximum amplitude of the pleth signal, or a value indicative of a respiratory-related plethysmographic waveform variation). The processor then outputs the pattern or value indicative of at least one pleth waveform component after standing and then compares the value or pattern prior to standing with the value or pattern after standing. Examples of input devices that can be used to detect when the patient stands include, for example, a patient-mounted position sensor or a manual input device such as a mouse or keyboard. In an exemplary embodiment of the present invention, a position sensor is worn by a patient to communicate postural position information about the patient to the processor. The processor can determine and/or calculate the difference between the pre-standing and post standing values. Exemplary embodiments of the present invention may provide an orthostasis detection system that is simple, inexpensive, non-invasive, automated, and can be employed in a long-term ambulatory state.
[0006] One exemplary embodiment of detecting orthostasis according to the present invention comprises measuring at least one pleth waveform component, inputting the occurrence of a maneuver on a patient into a processor, measuring at least one pleth waveform component after the maneuver, comparing the pleth waveform component measured before the maneuver to the pleth waveform component after the maneuver. Another exemplary embodiment includes the acts of deriving a time series of a pleth waveform component, providing an indication of the time of at least one maneuver along the time series and outputting the time series.
Another exemplary embodiment may include the act of comparing a pleth waveform pattern before a maneuver to the pleth waveform pattern after the maneuver.
[00071 FIG. 1 is a block diagram of a system that is adapted to analyze data corresponding to variations in a plethysmographic pulse signal in accordance with an exemplary embodiment of the present invention. The system is generally referred to by the reference number 100. The system 100 comprises a pulse oximeter 102, which is connected to a processor 104. The processor 104 may be programmed to perform calculations and analysis on data corresponding to variations in a plethysmographic pulse signal. In the exemplary embodiment illustrated in FIG.
1, the pulse oximeter 102 is adapted to receive plethysmographic pulse data from a plethysmographic sensor 106, which may be connected to a patient. In an alternative embodiment, the processor 104 may be adapted to analyze previously obtained data stored in a memory 108, which is coupled to the processor 104. The exemplary system 100 may include an input device 110 to signal the performance of a maneuver by or on a patient. In this way, data being evaluated by the system 100 may be analyzed in the context of when it occurred relative to the performance of the maneuver. While an exemplary embodiment of the invention comprises the pulse oximeter 102.
other devices that detect and/or monitor a hemodynamic pulse related parameter such as, for example, a pressure transduced arterial catheter, a continuous blood pressure monitor, or a digital volumetric plethysmograph, to name a few, may be employed to detect the hemodynamic and systolic pressure variations discussed below. The system 100 may additionally include an output device 112, such as a printer, display device, alarm or the like. The output device 112 may be adapted to signal or provide an indication of a condition detected by the processor 104.
[0008] Those of ordinary skill in the art appreciate that the detection and quantification of at least one pleth waveform component (such as magnitude of the respiratory related variation of the pleth) is possible. One method of processing the pleth signal is described in U.S. Patent No.
7,081,095 (the contents of which are incorporated by reference as if completely disclosed herein).
An example of a pleth waveform component is the pleth variation associated with ventilation as calculated from the plethysmographic pulse of the pulse oximeter 102, which is a sensitive indicator of intravascular blood volume in patients undergoing mechanical ventilation. The plethysmographic waveform (or pulse) variation can, for example, be outputted as a percentage of the peak pleth amplitude (see, for example, Pulse Oximetry Plethysmographic Waveform During Changes in Blood Volume, British Journal of Anesthesia, 82 (2): 178-81 (1999), the contents of which are hereby incorporated by reference as if completely disclosed herein).
100091 However, while a decrease in effective venous return (as induced by a decrease in blood volume) commonly increases the respiratory-related pleth waveform (or systolic pressure) variation, a rise in respiratory effort can also increase this variation so that the linkage of this variation to the intravascular volume becomes much more complex in spontaneously breathing patients. Simplistic approaches, which attempt to determine the trend of the this plethysmographic waveform variation to determine blood volume, can provide a false trend which may suggest a falling blood volume due to a plethysmographic waveform variation cased by a rising respiratory effort due to bronchospasm, pulmonary embolism, or even an excess in blood volume inducing pulmonary edema.
[0010] The inventors of the present invention has recognized that, because the pleth waveform variation increases with both a fall in effective venous return or an increase in respiratory effort (which can be associated with excess venous return and heart failure and increases in lung water), the pattern of the pleth waveform variation (or other pleth waveform components) are best analyzed in timed relation to a maneuver (such as a standing maneuver), which is known to reduce venous return, especially in disease states and in the presence of certain medications or in states of low blood volume so that the relationship of the change in pleth waveform variation to the maneuver can be determined to thereby better establish the presence of reduced venous return and to identify when the magnitude of venous return and/or the vasoconstrictive arterial response to a decline in venous return, is abnormal.
[0011] In an exemplary embodiment of the present invention, the processor 104 is programmed to detect a falling SPO2 combined with a rising magnitude of the pleth respiratory variation or a change or a pattern of change in a plethysmographic pulse component in relation to a maneuver that potentially reduces venous return, such as standing. In an exemplary embodiment of the present invention, the processor 104 can be programmed, as by using an objectification method, to convert the plethysmographic time series into program objects such as dipoles (see, e.g. U.S. Patent Application Serial No. 10/150,842 filed on August 21, 2003 (now U.S. Patent Publication No. 20030158466), the contents of which are incorporated by reference as if completely disclosed herein) and objects comprised of events such as rises and falls and reciprocations (fundamental level).
[0012] Reciprocation objects can be defined by the user or by adaptive processing, as a threshold or pattern of reduction of amplitude, peak value, nadir value, slope, area under the curve (AUC) or the like. The components of the rises and falls such as the peaks, the nadirs, the slopes, or the AUC, to name a few, can be applied to render the composite level of the plethysmographic time series. The pattern of the reciprocations of one or more of these values (the composite level) can use used to detect respiration rate wherein the respiration rate is defined as the average number of reciprocations at the composite level per minute. More complex variations in the pattern of the plethysmographic pulse will also be detectable at the composite level such as apneas or sustained variations in blood flow to the finger (as, for example, may be induced by a mechanical ventilator setting change or a change in body position from the supine to the upright position). The SPO2 can be similarly processed in parallel with the pulse and the pattern of the pulse at the any level of the pulse compared with the pattern of the SPO2 at any level.
[0013] In an exemplary embodiment of the present invention, the number of reciprocations per minute and/or the magnitude of the amplitude of the reciprocations, amplitude, as determined by calculating the number of reciprocations per minute, is compared using the processor 104 with the time series of the SPO2 at, for example, the raw, dipole or fundamental level. The relationship between these two time series determined by the processor 104 may be used to detect and quantify the relationship between the ventilation time series (derived of the plethysmographic pulse) and the oxygen saturation time series.
[00141 In an exemplary embodiment of the present invention, the processor 104 is programmed to detect a change (such as a fall) in a plethysmographic pulse component (as for example the components noted above) in response to a maneuver, which affects venous return to the heart. Examples of such maneuvers include changes in a mechanical ventilator (such as an increase in positive pressure delivery to the patient, an increase in positive and expiratory pressure delivery to the patient, a change or changes in tidal volume, PEEP, respiration rate, or I:E ratio).
Other maneuvers can include having the patient stand up from a supine position to detect a positional variation in the plethysmographic pulse parameter. The processor 104 can be programmed to automatically detect the maneuver or to receive an input from the input device 110 indicative of the occurrence or pattern of the maneuver. In an exemplary embodiment of the present invention, the input device 110 can be accessed through a menu which can allow the user to specify the maneuver (such as standing or exercising).
100151 In an exemplary embodiment of the present invention, the processor 104 is adapted to detect orthostasis. An input is provided via the input device 110 when the patient undergoes a maneuver such as a change in body position (for example, standing up). The beginning of the maneuver may be taken into account when analyzing the corresponding SPO2, respiration and ventilation data. A variation in a least one component of the plethysmographic pulse may be quantified and a relationship between the variation and the maneuver may be identified. By way of example, a fall in the average pleth amplitude (such as the systolic variation ) of about 20% or more in response to standing can result in an output that indicates to an.attendant that there is a need to check the blood pressure in the supine and standing position.
Alternatively, the processor 104 can be programmed to detect an increase in the reciprocation amplitude at the composite level of about 20-40% or more can output an indication of the presence and/or magnitude and/or pattern of orthostatic variation in the pleth amplitude pattern. In one exemplary embodiment of the present invention, the pulse oximeter 102 is adapted to be used for spot checks of the SPO2. The system may also be adapted to display a menu on, for example, either the input device 110 or the output device 112 depending on system design considerations. A user may specify that one or more orthostatic variation maneuver(s) is (are) to be initiated via the menu.
The user may then be instructed to press a button or touch the screen at the time the patient stands up. The processor 104 tracks the pattern of the pleth and outputs and detects threshold pattern changes or lack thereof as noted above. An indication (such as a textual indication or alarm) of the presence or absence of threshold orthostatic variation value and/or pattern may be provided. In addition, the slope or other components of the pattern of the variation subsequent to the maneuver can be determined and quantified. A time series indicative of the variation with the points of the standing or other position change marked along the time series may be outputted for over reading by the physician. Furthermore, a time series of one or more of the maneuvers may also be created. A time series of pleth variation data may be compared to the time series of one or more maneuvers.
[0016] In an alternative embodiment of the invention, the input device 110 comprises a position sensor adapted to be mounted in connection and/or in communication with one or more components of the system 100. The position sensor, which may be mounted to the chest of a patient during sleep studies, can alternatively be configured for mounting on the thigh of the patient so that detection of the change form recumbent to standing or sitting to standing is automatically performed by the position sensor. The plethysmographic monitor system 100 can have memory such as the memory 108 in wired and/or wireless communication therewith to allow ambulatory detection and quantification of the time series pattern of at least one plethysmographic pulse variation (such as a time series of the systolic pleth variation) in relation to variations in body position over a time interval such as 8-24 hours or more. Moreover, hemodynamic variation data may be obtained by ambulating a patient who is wearing a mobile hemodynamic variation detector. One example of ambulating the patient includes standing the patient while the patient is wearing a mobile hemodynamic variation detector. An exemplary embodiment of the present invention provides an ambulatory orthostasis detection system useful for titration of medications known to cause orthostasis. For example, the orthostasis monitor may be wrist mounted with the probe extending to the index finger. Such systems can be useful for the titration of medications used for the treatment of dementia in nursing homes or in the home environment. The system can also be used to titrate medication used for the treatment of heart failure or hypertension and for the ambulatory investigation of the cause of syncope or lightheadedness.
100171 In an exemplary embodiment of the present invention, the processor 104 is programmed to compare a time series of body position to a parallel time series of at least one component of the pleth variation. The time series of at least one component of the pleth variation is analyzed to detect patterns, which occur in relation to changes in body position. In addition, the pattern of the heart rate can be identified in relation to body position so that heart rate acceleration can be detected and quantified for example.
[0018] In another exemplary embodiment of the present invention, the plethysmographic monitor system 100 serves as a pulse rate and pattern detection system. The processor 104 is programmed to determine the time intervals of the pleth including the time between pulses, and the time of systole, the time of diastole, the time of the rise, the time of the fall, and the pattern of pulses. Different patterns can be detected such as the pattern of atrial fibrillation (for example, identified by detecting an irregularly irregular interval between pulses and/or an irregularly irregular pulse amplitude), or a paroxysmal tachycardia (for example, detected by noting a precipitous increase in pulse rate which resolves precipitously). This pulse rhythm and pulse amplitude diagnostic function is complementary to the orthostasis detection function for the evaluation of lightheadedness and syncope.
[0019] In yet another exemplary embodiment of the present invention, a time series of the respiratory rate (as for example determined from the pleth), a time series of the pleth variation, and a time series of the SPO2 are compared to identify the pattern relationships between these parameters such as a rise in pleth variation and a fall in SPO2, a rise in pleth variation and rise in respiratory rate, and/or a rise in respiratory rate and a fall in SPO2 and /or in relation to a maneuver such as standing. The processor 104 may be programmed to detect pathophysiologic divergence of the respiratory rate and/or the pleth variation and/or the SPO2.
[0020] In an exemplary embodiment of the present invention, an associated processor may be programmed to detect an oxygen saturation parameter (such as the ratio of ratios and/or the SPO2) and a respiration parameter (such as the respiration rate) and a magnitude of pleth variation. For example, the magnitude of pleth variation may be determined by the pleth amplitude and/or pleth slope variation. The pattern of the time series of the respiratory rate may then be compared with the pattern of the SPO2 to detect and abnormal relationship, such as pathophysiologic divergence with an increasing difference between the respiratory rate and the SPO2, for example. The processor may be programmed to output an indication based on the detection of the pattern or absolute value of the relationship and/or to output an index value indicative the relationship. The detection of a rise in respiration rate associated with a fall in plethysmographic pulse variation can be detected, quantified, and the pattern of the relationship analyzed and tracked by the processor.
The processor can be programmed to provide an updated indication of the relationship and the pattern of the relationship to the user. The method of processing can, for example, be of the type discussed in U.S. Patent No. 7,081,095 (the contents of which is incorporated by reference as if completely disclosed herein). In an exemplary embodiment of the present invention, a plurality of parameters are combined to determine the global respiratory variation, including the amplitude of the events (at the fundamental level), the variation of the peak values (fundamental level), and the variation of the nadirs (also fundamental level).
[0021] The system 100 may comprise an optional ventilator 114 operatively coupled to the processor 104. The ventilator 114 may comprise an airflow generator 116 that is adapted to an airflow to a patient. The processor 104 may be programmed so that the time series of the systolic pleth variation (for example) is displayed on the output device 112 adjacent a time series of at least one ventilation parameter. The processor 104 can be programmed for example to detect a pattern or threshold increase in systolic pressure variation in relation to a ventilator change and to output an indication of the pattern or threshold increase to the operator.
[0022] FIG. 2 is a process flow diagram illustrating a method of processing patient data in accordance with an exemplary embodiment of the present invention. The diagram is generally referred to by the reference number 200. At block 202, the process begins.
[0023] At block 204, hemodynamic variation data is obtained. The hemodynamic variation data, which corresponds to a variation in intravascular hemodynamics of a patient, may be obtained, for example, from a memory device or directly from monitoring a patient in real time.
At block 206, the hemodynamic variation data is searched for an indication of orthostasis in response to a maneuver performed on or by the patient. An output, such as an alarm, printout and/or display, is generated if the indication of orthostasis is detected, as indicated at block 208.
At block 210, the process ends.
[0024] One exemplary embodiment of the present invention comprises a method for determining the proper dose of a medication comprising administering the medication, monitoring the patient for orthostasis using the aforementioned methods, adjusting the dose of the medication based on the monitoring. The medications can include, for example, tricyclic antidepressants, MOAI, atypical antipsychotic agents, dopamine agonists, Flomax, Hytrin, diuretics, calcium channel blockers, and ACE inhibitors to name a few. Another exemplary embodiment comprises monitoring the patients with diseases or disorders for orthostasis using the aforementioned methods. The diseases or disorders can include, for example, dementia, Parkinsonian syndromes, diabetic neuropathy, and/or POTS to name a few.
[0025] In one exemplary embodiment of the present invention, an automated BP
device is modified to perform automated orthostasis evaluation on demand. The processor of the device is programmed to first measure the blood pressure, automatically or manually receive an input of a maneuver, such as a standing maneuver, then automatically acquire consecutive blood pressure readings in rapid sequence to determine and record a time series of blood pressure readings after the maneuver and to output an indication based on the time series. The automatic blood pressure device can be programmed to display a menu offering the operator an automated orthostasis evaluation. The processor can be programmed to constrict the cuff on the second measurement to a point to a lower pressure point than the systolic pressure (such as the point wherein the diastolic pressure had been identified on the first measurement) and then to record and analyze the pulse tracing detected under the partially constricted cuff (as by the aforementioned methods) for pulse variations during and after a maneuver. In one exemplary embodiment, the automated BP cuffs provide a selection in its display for orthostasis evaluation so the orthostasis can become a standard vital sign for some patient populations.
[0026] While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
Claims (19)
1. A system that is adapted to monitor patient data, comprising:
a plethysomographic sensor adapted to obtain hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
a processor that is adapted to search the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and an output device that is adapted to generate an output if the indication orthostasis is discovered.
a plethysomographic sensor adapted to obtain hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
a processor that is adapted to search the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and an output device that is adapted to generate an output if the indication orthostasis is discovered.
2. The system recited in claim 1, comprising a mobile hemodynamic variation detector disposed on the patient, the mobile hemodynamic variation detector being adapted to deliver the hemodynamic variation data to the processor.
3. The system recited in claim 1, wherein the processor is adapted to detect an occurrence of the positional maneuver.
4. The system recited in claim 1, comprising a mobile hemodynamic variation detector disposed on the patient, the mobile hemodynamic variation detector being adapted to deliver the hemodynamic variation data to the processor when the positional maneuver comprises moving from a supine position to a standing position.
5. The system recited in claim 1, comprising a position sensor that is adapted to provide data corresponding to a postural position of the patient.
6. The system recited in claim 1, wherein the processor is adapted to generate a time series of the hemodynamic variation data.
7. The system recited in claim 6, wherein the processor is adapted to:
detect an occurrence of the positional maneuver; and detect along the time series an indication of orthostasis in association with the occurrence of the positional maneuver.
detect an occurrence of the positional maneuver; and detect along the time series an indication of orthostasis in association with the occurrence of the positional maneuver.
8. The system recited in claim 7, wherein the processor is adapted to:
detect an occurrence of the positional maneuver; and detect along the time series an indication of orthostasis subsequent to the occurrence of the positional maneuver.
detect an occurrence of the positional maneuver; and detect along the time series an indication of orthostasis subsequent to the occurrence of the positional maneuver.
9. The system recited in claim 1, wherein the processor is adapted to:
detect a plurality of sequential positional maneuvers; and detect along the time series an indication of orthostasis in association with at least one of the plurality of sequential positional maneuvers.
detect a plurality of sequential positional maneuvers; and detect along the time series an indication of orthostasis in association with at least one of the plurality of sequential positional maneuvers.
10. The system recited in claim 1, wherein the processor is adapted to receive an input indicative of the occurrence of the positional maneuver.
11. The system recited in claim 1, wherein the positional maneuver comprises a standing maneuver.
12. A system for monitoring patient data, comprising:
means for obtaining hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
means for searching the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and means for generating an output if the indication orthostasis is discovered.
means for obtaining hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
means for searching the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and means for generating an output if the indication orthostasis is discovered.
13. A tangible machine-readable medium, comprising:
code adapted to obtain hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
code adapted to search the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and code adapted to generate an output if the indication orthostasis is discovered.
code adapted to obtain hemodynamic variation data that corresponds to a variation in intravascular hemodynamics of a patient;
code adapted to search the hemodynamic variation data for an indication of orthostasis in response to the occurrence of a positional maneuver of or by the patient; and code adapted to generate an output if the indication orthostasis is discovered.
14. The tangible medium recited in claim 13, comprising code adapted to detect an occurrence of the positional maneuver.
15. The tangible medium recited in claim 13, comprising code adapted to generate a time series of the hemodynamic variation data.
16. The tangible medium recited in claim 13, comprising:
code adapted to detect an occurrence of the positional maneuver; and code adapted to detect along the time series an indication of orthostasis in association with the occurrence of the positional maneuver.
code adapted to detect an occurrence of the positional maneuver; and code adapted to detect along the time series an indication of orthostasis in association with the occurrence of the positional maneuver.
17. The tangible medium recited in claim 13, comprising:
code adapted to detect an occurrence of the positional maneuver; and code adapted to detect along the time series an indication of orthostasis subsequent to the occurrence of the positional maneuver.
code adapted to detect an occurrence of the positional maneuver; and code adapted to detect along the time series an indication of orthostasis subsequent to the occurrence of the positional maneuver.
18. The tangible medium recited in claim 13, comprising:
code adapted to detect a plurality of sequential positional maneuvers; and code adapted to detect along the time series an indication of orthostasis in association with at least one of the plurality of sequential positional maneuvers.
code adapted to detect a plurality of sequential positional maneuvers; and code adapted to detect along the time series an indication of orthostasis in association with at least one of the plurality of sequential positional maneuvers.
19. The tangible medium recited in claim 13, comprising code adapted to receive an input indicative of the occurrence of the positional maneuver.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/708,314 US20080200819A1 (en) | 2007-02-20 | 2007-02-20 | Orthostasis detection system and method |
| US11/708,314 | 2007-02-20 | ||
| PCT/US2008/002254 WO2008103390A2 (en) | 2007-02-20 | 2008-02-20 | Orthostasis detection system and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2678776A1 true CA2678776A1 (en) | 2008-08-28 |
Family
ID=39590746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002678776A Abandoned CA2678776A1 (en) | 2007-02-20 | 2008-02-20 | Orthostasis detection system and method |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20080200819A1 (en) |
| EP (1) | EP2114243A2 (en) |
| JP (1) | JP2010518970A (en) |
| CA (1) | CA2678776A1 (en) |
| WO (1) | WO2008103390A2 (en) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050288571A1 (en) * | 2002-08-20 | 2005-12-29 | Welch Allyn, Inc. | Mobile medical workstation |
| US7578793B2 (en) | 2004-11-22 | 2009-08-25 | Widemed Ltd. | Sleep staging based on cardio-respiratory signals |
| US7846106B2 (en) * | 2006-04-26 | 2010-12-07 | The General Electric Company | Atrial fibrillation detection using SPO2 |
| US7806832B2 (en) * | 2007-04-30 | 2010-10-05 | The General Electric Company | False positive reduction in SPO2 atrial fibrillation detection using average heart rate and NIBP |
| EP2313138B1 (en) | 2008-03-31 | 2018-09-12 | Covidien LP | System and method for determining ventilator leakage during stable periods within a breath |
| US8267085B2 (en) | 2009-03-20 | 2012-09-18 | Nellcor Puritan Bennett Llc | Leak-compensated proportional assist ventilation |
| US8272379B2 (en) | 2008-03-31 | 2012-09-25 | Nellcor Puritan Bennett, Llc | Leak-compensated flow triggering and cycling in medical ventilators |
| US8746248B2 (en) | 2008-03-31 | 2014-06-10 | Covidien Lp | Determination of patient circuit disconnect in leak-compensated ventilatory support |
| US8251876B2 (en) | 2008-04-22 | 2012-08-28 | Hill-Rom Services, Inc. | Breathing exercise apparatus |
| US8457706B2 (en) | 2008-05-16 | 2013-06-04 | Covidien Lp | Estimation of a physiological parameter using a neural network |
| US8551006B2 (en) * | 2008-09-17 | 2013-10-08 | Covidien Lp | Method for determining hemodynamic effects |
| US8302602B2 (en) | 2008-09-30 | 2012-11-06 | Nellcor Puritan Bennett Llc | Breathing assistance system with multiple pressure sensors |
| US8424521B2 (en) | 2009-02-27 | 2013-04-23 | Covidien Lp | Leak-compensated respiratory mechanics estimation in medical ventilators |
| US8418691B2 (en) | 2009-03-20 | 2013-04-16 | Covidien Lp | Leak-compensated pressure regulated volume control ventilation |
| US20100324431A1 (en) * | 2009-06-18 | 2010-12-23 | Nellcor Puritan Bennett Ireland | Determining Disease State Using An Induced Load |
| US8789529B2 (en) | 2009-08-20 | 2014-07-29 | Covidien Lp | Method for ventilation |
| US8638200B2 (en) | 2010-05-07 | 2014-01-28 | Covidien Lp | Ventilator-initiated prompt regarding Auto-PEEP detection during volume ventilation of non-triggering patient |
| US9220444B2 (en) * | 2010-06-07 | 2015-12-29 | Zephyr Technology Corporation | System method and device for determining the risk of dehydration |
| US8607788B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of triggering patient exhibiting obstructive component |
| US8607789B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during volume ventilation of non-triggering patient exhibiting obstructive component |
| US8607790B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation of patient exhibiting obstructive component |
| US8607791B2 (en) | 2010-06-30 | 2013-12-17 | Covidien Lp | Ventilator-initiated prompt regarding auto-PEEP detection during pressure ventilation |
| US8676285B2 (en) | 2010-07-28 | 2014-03-18 | Covidien Lp | Methods for validating patient identity |
| US8554298B2 (en) | 2010-09-21 | 2013-10-08 | Cividien LP | Medical ventilator with integrated oximeter data |
| US8757153B2 (en) | 2010-11-29 | 2014-06-24 | Covidien Lp | Ventilator-initiated prompt regarding detection of double triggering during ventilation |
| US8595639B2 (en) | 2010-11-29 | 2013-11-26 | Covidien Lp | Ventilator-initiated prompt regarding detection of fluctuations in resistance |
| US8757152B2 (en) | 2010-11-29 | 2014-06-24 | Covidien Lp | Ventilator-initiated prompt regarding detection of double triggering during a volume-control breath type |
| US9038633B2 (en) | 2011-03-02 | 2015-05-26 | Covidien Lp | Ventilator-initiated prompt regarding high delivered tidal volume |
| US9089657B2 (en) | 2011-10-31 | 2015-07-28 | Covidien Lp | Methods and systems for gating user initiated increases in oxygen concentration during ventilation |
| US9180271B2 (en) | 2012-03-05 | 2015-11-10 | Hill-Rom Services Pte. Ltd. | Respiratory therapy device having standard and oscillatory PEP with nebulizer |
| US9993604B2 (en) | 2012-04-27 | 2018-06-12 | Covidien Lp | Methods and systems for an optimized proportional assist ventilation |
| US9027552B2 (en) | 2012-07-31 | 2015-05-12 | Covidien Lp | Ventilator-initiated prompt or setting regarding detection of asynchrony during ventilation |
| US9953453B2 (en) | 2012-11-14 | 2018-04-24 | Lawrence A. Lynn | System for converting biologic particle density data into dynamic images |
| US10354429B2 (en) | 2012-11-14 | 2019-07-16 | Lawrence A. Lynn | Patient storm tracker and visualization processor |
| WO2014134460A1 (en) | 2013-02-28 | 2014-09-04 | Lynn Lawrence A | Time lapsable motion image responsive to features of pathophysiologic perturbations |
| US9675771B2 (en) | 2013-10-18 | 2017-06-13 | Covidien Lp | Methods and systems for leak estimation |
| WO2015173679A1 (en) * | 2014-05-12 | 2015-11-19 | Koninklijke Philips N.V. | Motion triggered vital sign measurement |
| US11589758B2 (en) * | 2016-01-25 | 2023-02-28 | Fitbit, Inc. | Calibration of pulse-transit-time to blood pressure model using multiple physiological sensors and various methods for blood pressure variation |
| JP6766708B2 (en) * | 2017-03-15 | 2020-10-14 | オムロンヘルスケア株式会社 | Information processing equipment, methods and programs |
| JP7170459B2 (en) * | 2018-08-10 | 2022-11-14 | 株式会社東芝 | Blood circulation detection device, method, and program |
| US11607275B2 (en) * | 2019-05-20 | 2023-03-21 | Medtronic Ireland Manufacturing Unlimited Company | Selection of hypertensive patients for treatment with renal denervation |
Family Cites Families (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US673866A (en) | 1900-10-25 | 1901-05-14 | St Louis Wooden Ware Works | Washboard. |
| US3638640A (en) * | 1967-11-01 | 1972-02-01 | Robert F Shaw | Oximeter and method for in vivo determination of oxygen saturation in blood using three or more different wavelengths |
| US4911167A (en) * | 1985-06-07 | 1990-03-27 | Nellcor Incorporated | Method and apparatus for detecting optical pulses |
| US4936679A (en) * | 1985-11-12 | 1990-06-26 | Becton, Dickinson And Company | Optical fiber transducer driving and measuring circuit and method for using same |
| US4913150A (en) * | 1986-08-18 | 1990-04-03 | Physio-Control Corporation | Method and apparatus for the automatic calibration of signals employed in oximetry |
| US4805623A (en) * | 1987-09-04 | 1989-02-21 | Vander Corporation | Spectrophotometric method for quantitatively determining the concentration of a dilute component in a light- or other radiation-scattering environment |
| US4807631A (en) * | 1987-10-09 | 1989-02-28 | Critikon, Inc. | Pulse oximetry system |
| US5873821A (en) * | 1992-05-18 | 1999-02-23 | Non-Invasive Technology, Inc. | Lateralization spectrophotometer |
| US5122974A (en) * | 1989-02-06 | 1992-06-16 | Nim, Inc. | Phase modulated spectrophotometry |
| EP0374668A3 (en) * | 1988-12-16 | 1992-02-05 | A.W. Faber - Castell GmbH & Co. | Fluorescent marking fluid |
| US5119815A (en) * | 1988-12-21 | 1992-06-09 | Nim, Incorporated | Apparatus for determining the concentration of a tissue pigment of known absorbance, in vivo, using the decay characteristics of scintered electromagnetic radiation |
| US6183414B1 (en) * | 1999-04-26 | 2001-02-06 | Michael S. Wysor | Technique for restoring plasticity to tissues of a male or female organ |
| US6708048B1 (en) * | 1989-02-06 | 2004-03-16 | Non-Invasive Technology, Inc. | Phase modulation spectrophotometric apparatus |
| US5483646A (en) * | 1989-09-29 | 1996-01-09 | Kabushiki Kaisha Toshiba | Memory access control method and system for realizing the same |
| US5190038A (en) * | 1989-11-01 | 1993-03-02 | Novametrix Medical Systems, Inc. | Pulse oximeter with improved accuracy and response time |
| DE3938759A1 (en) * | 1989-11-23 | 1991-05-29 | Philips Patentverwaltung | NON-INVASIVE OXIMETER ARRANGEMENT |
| US6681128B2 (en) * | 1990-10-06 | 2004-01-20 | Hema Metrics, Inc. | System for noninvasive hematocrit monitoring |
| WO1992015955A1 (en) * | 1991-03-07 | 1992-09-17 | Vital Signals, Inc. | Signal processing apparatus and method |
| US5995855A (en) * | 1998-02-11 | 1999-11-30 | Masimo Corporation | Pulse oximetry sensor adapter |
| US6580086B1 (en) * | 1999-08-26 | 2003-06-17 | Masimo Corporation | Shielded optical probe and method |
| DE4138702A1 (en) * | 1991-03-22 | 1992-09-24 | Madaus Medizin Elektronik | METHOD AND DEVICE FOR THE DIAGNOSIS AND QUANTITATIVE ANALYSIS OF APNOE AND FOR THE SIMULTANEOUS DETERMINATION OF OTHER DISEASES |
| US6549795B1 (en) * | 1991-05-16 | 2003-04-15 | Non-Invasive Technology, Inc. | Spectrophotometer for tissue examination |
| US5385143A (en) * | 1992-02-06 | 1995-01-31 | Nihon Kohden Corporation | Apparatus for measuring predetermined data of living tissue |
| US5297548A (en) * | 1992-02-07 | 1994-03-29 | Ohmeda Inc. | Arterial blood monitoring probe |
| US5263244A (en) * | 1992-04-17 | 1993-11-23 | Gould Inc. | Method of making a flexible printed circuit sensor assembly for detecting optical pulses |
| EP0572684B1 (en) * | 1992-05-15 | 1996-07-03 | Hewlett-Packard GmbH | Medical sensor |
| US6785568B2 (en) * | 1992-05-18 | 2004-08-31 | Non-Invasive Technology Inc. | Transcranial examination of the brain |
| US5355880A (en) * | 1992-07-06 | 1994-10-18 | Sandia Corporation | Reliable noninvasive measurement of blood gases |
| US7758503B2 (en) | 1997-01-27 | 2010-07-20 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
| US7081095B2 (en) | 2001-05-17 | 2006-07-25 | Lynn Lawrence A | Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions |
| CA2155932A1 (en) * | 1993-12-14 | 1995-06-22 | Tadakazu Yamauchi | Medical measuring apparatus |
| DE4423597C1 (en) * | 1994-07-06 | 1995-08-10 | Hewlett Packard Gmbh | Pulsoximetric ear sensor |
| US7035697B1 (en) * | 1995-05-30 | 2006-04-25 | Roy-G-Biv Corporation | Access control systems and methods for motion control |
| US5758644A (en) * | 1995-06-07 | 1998-06-02 | Masimo Corporation | Manual and automatic probe calibration |
| DE59704665D1 (en) * | 1996-04-01 | 2001-10-25 | Linde Medical Sensors Ag Basel | DETECTION OF INTERFERENCE SIGNALS IN PULSOXYMETRIC MEASUREMENT |
| US6163715A (en) * | 1996-07-17 | 2000-12-19 | Criticare Systems, Inc. | Direct to digital oximeter and method for calculating oxygenation levels |
| US6544193B2 (en) * | 1996-09-04 | 2003-04-08 | Marcio Marc Abreu | Noninvasive measurement of chemical substances |
| US5871442A (en) * | 1996-09-10 | 1999-02-16 | International Diagnostics Technologies, Inc. | Photonic molecular probe |
| US6081742A (en) * | 1996-09-10 | 2000-06-27 | Seiko Epson Corporation | Organism state measuring device and relaxation instructing device |
| AU7934498A (en) * | 1997-06-27 | 1999-01-19 | Toa Medical Electronics Co., Ltd. | Living body inspecting apparatus and noninvasive blood analyzer using the same |
| US6371114B1 (en) * | 1998-07-24 | 2002-04-16 | Minnesota Innovative Technologies & Instruments Corporation | Control device for supplying supplemental respiratory oxygen |
| DE69940053D1 (en) * | 1998-02-05 | 2009-01-22 | Hema Metrics Inc | METHOD AND DEVICE FOR NON-INVASIVE OBSERVATION OF BLOOD COMPONENTS |
| JP3576851B2 (en) * | 1998-03-23 | 2004-10-13 | キヤノン株式会社 | Liquid crystal display, video camera |
| US6662030B2 (en) * | 1998-05-18 | 2003-12-09 | Abbott Laboratories | Non-invasive sensor having controllable temperature feature |
| US6842635B1 (en) * | 1998-08-13 | 2005-01-11 | Edwards Lifesciences Llc | Optical device |
| JP2000083933A (en) * | 1998-07-17 | 2000-03-28 | Nippon Koden Corp | Instrument for measuring concentration of light absorptive material in vital tissue |
| KR100293997B1 (en) * | 1998-08-10 | 2001-07-12 | 윤종용 | Method for displaying status of cordless telephone set |
| US6064898A (en) * | 1998-09-21 | 2000-05-16 | Essential Medical Devices | Non-invasive blood component analyzer |
| US6684090B2 (en) * | 1999-01-07 | 2004-01-27 | Masimo Corporation | Pulse oximetry data confidence indicator |
| US6675029B2 (en) * | 1999-07-22 | 2004-01-06 | Sensys Medical, Inc. | Apparatus and method for quantification of tissue hydration using diffuse reflectance spectroscopy |
| US7904139B2 (en) * | 1999-08-26 | 2011-03-08 | Non-Invasive Technology Inc. | Optical examination of biological tissue using non-contact irradiation and detection |
| US6618042B1 (en) * | 1999-10-28 | 2003-09-09 | Gateway, Inc. | Display brightness control method and apparatus for conserving battery power |
| JP2001149349A (en) * | 1999-11-26 | 2001-06-05 | Nippon Koden Corp | Sensor for living body |
| US6711424B1 (en) * | 1999-12-22 | 2004-03-23 | Orsense Ltd. | Method of optical measurement for determing various parameters of the patient's blood |
| IL135077A0 (en) * | 2000-03-15 | 2001-05-20 | Orsense Ltd | A probe for use in non-invasive measurements of blood related parameters |
| ES2392818T3 (en) * | 2000-04-17 | 2012-12-14 | Nellcor Puritan Bennett Llc | Pulse oximeter sensor with section function |
| US6650932B1 (en) * | 2000-05-15 | 2003-11-18 | Boston Medical Technologies, Inc. | Medical testing telemetry system |
| GB0014855D0 (en) * | 2000-06-16 | 2000-08-09 | Isis Innovation | Combining measurements from different sensors |
| US6889153B2 (en) * | 2001-08-09 | 2005-05-03 | Thomas Dietiker | System and method for a self-calibrating non-invasive sensor |
| IL138683A0 (en) * | 2000-09-25 | 2001-10-31 | Vital Medical Ltd | Apparatus and method for monitoring tissue vitality parameters |
| IL138884A (en) * | 2000-10-05 | 2006-07-05 | Conmed Corp | Pulse oximeter and a method of its operation |
| WO2002041771A1 (en) * | 2000-11-27 | 2002-05-30 | Modco Inc. | Apparatus and method for monitoring blood pressure and another physiological parameter |
| US6591122B2 (en) * | 2001-03-16 | 2003-07-08 | Nellcor Puritan Bennett Incorporated | Device and method for monitoring body fluid and electrolyte disorders |
| US6898451B2 (en) * | 2001-03-21 | 2005-05-24 | Minformed, L.L.C. | Non-invasive blood analyte measuring system and method utilizing optical absorption |
| JP2003047601A (en) * | 2001-05-31 | 2003-02-18 | Denso Corp | Organism abnormality monitoring system, blood pressure monitoring system, organism abnormality monitoring method and blood pressure monitoring method |
| US6697658B2 (en) * | 2001-07-02 | 2004-02-24 | Masimo Corporation | Low power pulse oximeter |
| DE10139379A1 (en) * | 2001-08-10 | 2003-03-06 | Siemens Ag | Inductive motion sensor has sensor coils beside permanent magnet field generator |
| IL145445A (en) * | 2001-09-13 | 2006-12-31 | Conmed Corp | Signal processing method and device for signal-to-noise improvement |
| US6738666B1 (en) * | 2001-11-01 | 2004-05-18 | Pacesetter, Inc. | Detection of orthostatic hypotension using positional data and cross-check data |
| US7162306B2 (en) * | 2001-11-19 | 2007-01-09 | Medtronic Physio - Control Corp. | Internal medical device communication bus |
| US7355512B1 (en) * | 2002-01-24 | 2008-04-08 | Masimo Corporation | Parallel alarm processor |
| US6822564B2 (en) * | 2002-01-24 | 2004-11-23 | Masimo Corporation | Parallel measurement alarm processor |
| CA2475726C (en) * | 2002-02-14 | 2010-02-09 | Toshinori Kato | Apparatus for evaluating biological function |
| WO2003071939A1 (en) * | 2002-02-22 | 2003-09-04 | Masimo Corporation | Active pulse spectraphotometry |
| JP2005535359A (en) * | 2002-02-22 | 2005-11-24 | デイテックス−オーメダ インコーポレイテッド | Monitoring physiological parameters based on fluctuations in photoplethysmographic signals |
| US6863652B2 (en) * | 2002-03-13 | 2005-03-08 | Draeger Medical Systems, Inc. | Power conserving adaptive control system for generating signal in portable medical devices |
| US6690958B1 (en) * | 2002-05-07 | 2004-02-10 | Nostix Llc | Ultrasound-guided near infrared spectrophotometer |
| US6711425B1 (en) * | 2002-05-28 | 2004-03-23 | Ob Scientific, Inc. | Pulse oximeter with calibration stabilization |
| US7024235B2 (en) * | 2002-06-20 | 2006-04-04 | University Of Florida Research Foundation, Inc. | Specially configured nasal pulse oximeter/photoplethysmography probes, and combined nasal probe/cannula, selectively with sampler for capnography, and covering sleeves for same |
| JP4395068B2 (en) * | 2002-07-15 | 2010-01-06 | イタマール メディカル リミテッド | Body surface probe, apparatus, and method for non-invasive detection of medical conditions |
| WO2004047631A2 (en) * | 2002-11-22 | 2004-06-10 | Masimo Laboratories, Inc. | Blood parameter measurement system |
| JP3661686B2 (en) * | 2002-12-19 | 2005-06-15 | 松下電器産業株式会社 | Monitoring device |
| US7230529B2 (en) * | 2003-02-07 | 2007-06-12 | Theradoc, Inc. | System, method, and computer program for interfacing an expert system to a clinical information system |
| KR100571811B1 (en) * | 2003-05-09 | 2006-04-17 | 삼성전자주식회사 | Ear type measurement apparatus for bio signal |
| US7047056B2 (en) * | 2003-06-25 | 2006-05-16 | Nellcor Puritan Bennett Incorporated | Hat-based oximeter sensor |
| US7373193B2 (en) * | 2003-11-07 | 2008-05-13 | Masimo Corporation | Pulse oximetry data capture system |
| US20050113651A1 (en) * | 2003-11-26 | 2005-05-26 | Confirma, Inc. | Apparatus and method for surgical planning and treatment monitoring |
| JP4527425B2 (en) * | 2004-03-19 | 2010-08-18 | 日本赤十字社 | Autonomic nerve activity monitoring device, blood processing device, and blood collection device |
| US7551950B2 (en) * | 2004-06-29 | 2009-06-23 | O2 Medtech, Inc,. | Optical apparatus and method of use for non-invasive tomographic scan of biological tissues |
| US7343186B2 (en) * | 2004-07-07 | 2008-03-11 | Masimo Laboratories, Inc. | Multi-wavelength physiological monitor |
| CA2580399C (en) * | 2004-09-15 | 2015-07-07 | Itamar Medical Ltd. | Method and apparatus for non-invasively measuring physiological parameters, particularly blood flow and venous capacitance |
| JP4673031B2 (en) * | 2004-10-06 | 2011-04-20 | テルモ株式会社 | Autonomic nerve function evaluation device |
| US20070073361A1 (en) * | 2005-09-23 | 2007-03-29 | Bioq, Inc. | Medical device for restoration of autonomic and immune functions impaired by neuropathy |
| US7725146B2 (en) * | 2005-09-29 | 2010-05-25 | Nellcor Puritan Bennett Llc | System and method for pre-processing waveforms |
| US7941199B2 (en) * | 2006-05-15 | 2011-05-10 | Masimo Laboratories, Inc. | Sepsis monitor |
| US8203438B2 (en) * | 2008-07-29 | 2012-06-19 | Masimo Corporation | Alarm suspend system |
| US20100088346A1 (en) * | 2008-10-08 | 2010-04-08 | General Electric Company | Method and system for attaching objects to a data repository |
| WO2010051479A1 (en) * | 2008-10-31 | 2010-05-06 | Nellcor Puritan Bennett Llc | System and method for facilitating observation of monitored physiologic data |
-
2007
- 2007-02-20 US US11/708,314 patent/US20080200819A1/en not_active Abandoned
-
2008
- 2008-02-20 WO PCT/US2008/002254 patent/WO2008103390A2/en active Application Filing
- 2008-02-20 CA CA002678776A patent/CA2678776A1/en not_active Abandoned
- 2008-02-20 EP EP08725847A patent/EP2114243A2/en not_active Withdrawn
- 2008-02-20 JP JP2009550907A patent/JP2010518970A/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20080200819A1 (en) | 2008-08-21 |
| WO2008103390A2 (en) | 2008-08-28 |
| WO2008103390A3 (en) | 2008-10-30 |
| JP2010518970A (en) | 2010-06-03 |
| EP2114243A2 (en) | 2009-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20080200819A1 (en) | Orthostasis detection system and method | |
| US20220225883A1 (en) | Observational Heart Failure Monitoring System | |
| Yoon et al. | Cuff-less blood pressure estimation using pulse waveform analysis and pulse arrival time | |
| US20210186371A1 (en) | Method and apparatus for assessing respiratory distress | |
| RU2673379C2 (en) | Monitoring system and method for monitoring hemodynamic status of subject | |
| JP5281002B2 (en) | Portable automated monitoring of patients with congestive heart failure | |
| US10292662B2 (en) | Device and method for obtaining pulse transit time and/or pulse wave velocity information of a subject | |
| Naschitz et al. | Pulse transit time by R-wave-gated infrared photoplethysmography: review of the literature and personal experience | |
| EP1568314B1 (en) | Blood pressure measurement apparatus and method | |
| JP4695646B2 (en) | Non-invasive cardiac monitoring device and method | |
| US20080183232A1 (en) | Method and system for determining cardiac function | |
| US20120016251A1 (en) | System for Respiration Data Processing and Characterization | |
| US8465434B2 (en) | Method and system for detection of respiratory variation in plethysmographic oximetry | |
| US20240008759A1 (en) | Method and system for monitoring cardiopulmonary function using electrical impedance tomography | |
| JP2019527603A (en) | Sensor system and method for determining respiration type | |
| Rafols-de-Urquia et al. | Evaluation of a wearable device to determine cardiorespiratory parameters from surface diaphragm electromyography | |
| Mohapatra et al. | A yellow–orange wavelength-based short-term heart rate variability measurement scheme for wrist-based wearables | |
| US20180055373A1 (en) | Monitoring device to identify candidates for autonomic neuromodulation therapy | |
| US20100106030A1 (en) | Method and system for automated measurement of pulsus paradoxus | |
| US20160287092A1 (en) | Blood vessel mechanical signal analysis | |
| Rashid et al. | Monitoring the Cardiovascular Parameters (HR, RR, PBP) Under Pressure Situation | |
| Szaj et al. | First evaluation of the PTN-104 plethysmographic sensor for heart rate measurement |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |
Effective date: 20140220 |